JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> BioPharma Services >> Optimed
)

Optimed

Eurofins Optimed,
an eminence in Clinical Trials

For over three decades, Eurofins Optimed has orchestrated and executed Clinical Trials on behalf of sponsors from the Pharma, Biotech,
Medtech and Foodtech industries in order to help them develop life-saving and life-improving products.

Specialized in Early Clinical Development

Since we focus on Early Clinical Development, we are cognizant of the distinctive importance and the urgency of First-in-Human (FIH) and Early Phase clinical trials. We understand how to meet your every specific technical and operational requirements so that you can make the best science and data-driven go/no-go decisions in a timely manner.

Commitment to Quality and Compliance

Do not make concessions when it comes to the integrity of your clinical trial. Rigorous regulatory scrutiny is necessary and benefits everyone: patients, sponsors, regulators and clinical trial service providers. Quality transparency and accountability are the cornerstone of our success, and of yours.

 

Eurofins Optimed, your end-to-end GxP clinical trial solutions

Full-Service Clinical CRO
Clinical Trials Unit (CTU)
A-to-Z, from protocol design through to study report, Eurofins Optimed is your fully customizable one stop-shop spanning the entire ecosystem of clinical research solutions.
  • Clinical trial protocol

  • Regulatory affairs

  • Global trial and site management
  • Clinical project management, monitoring and vigilance
  • Subject recruitment
  • Biometry (Data management, biostatistics and study report)
  • Medical writing
  • Clinical biology and laboratory operations
  • API manufacturing, development and distribution (CDMO)
Dedicated to early clinical development in healthy volunteers and ambulatory patients.
  • Early QT assessment
  • Bioavailability/ bioequivalence
  • Biosimilars
  • Drug/Drug interaction
  • Food effect
  • Pharmacodynamics
  • Pharmacokinetics
  • Dose proportionality
  • First-in-Human (SAD, MAD)
  • Tobacco products
  • Vaccines
  • Muscle biopsy
  • Micro-dosing
  • Glucose clamp
  • Sleep evaluation